Prevention of trauma-induced neurodegeneration in infant and adult rat brain: Glutamate antagonists

Metabolic Brain Disease

Volumn 11, Issue 2, 1996, Pages 125-141

  Ikonomidou, Chrysanthy ^a   Turski, Lechoslaw ^b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b BAYER PHARMA AG   (Germany)

Author keywords

AMPA antagonist; glutamate antagonists; NMDA antagonists; Traumatic brain injury

Indexed keywords

4 (3 PHOSPHONOPROPYL) 2 PIPERAZINECARBOXYLIC ACID; 6 NITRO 7 SULFAMOYLBENZO[F]QUINOXALINE 2,3 DIONE; ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; DIZOCILPINE; GLUTAMATE RECEPTOR ANTAGONIST; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INJURY; CONTROLLED STUDY; HIPPOCAMPUS; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; NERVE CELL LESION; NERVE DEGENERATION; NEUROPROTECTION; NONHUMAN; RAT;

EID: 0029977724     PISSN: 08857490     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02069500     Document Type: Article

References (56)

1. Adams, J.H. (1992). Dead injury. In (J.H. Adams, and L.W. Duchen, eds) Greenfield's Neuropathology, (Arnold, London), pp. 106-152.
2. Albala, B.J., Moshe, S.L., and Okada, R. (1984). Kainic acid-induced seizures: a developmental, study. Dev. Bruin Rex. 13:139-148.
3. Benveniste. H., Drejer, J., Schousboe, A., and Diemer, N.H. (1984). Elevation of extracellular concentrations of glutamate and aspartate in rat hippocampus during transient cerebral ischemia monitored by intracerebral microdialysis. J. Neurochem. 43:1369-1374.
4. Ben-Ari, Y., Tremblay, E., Berger, M., and Nitecka, L. (1984). Kainic acid seizure syndrome and binding sites in developing rats. Dev. Brain Rex. 14:284-288.
5. Bernert, H., Mathias, S., Löschmann, P.-A., and Turski, L. (1994). Traumatic brain injury, prevented by the AMPA antagonist NBQX. Soc. Neurosci. Abstr. 20:977.
6. Bondoli, A., Barbi, S., Camaioni, D., Della Morte, F., Magalini, S.I. (1981). Plasma and cerebrospinal fluid free amino acid concentrations in post-traumatic cerebral oedema in patients with shock. Resuscitation 9:119-124.
7. Campociaro, P., and Coyle, J.T. (1978). Ontogenetic development of kainate neurotoxicity: correlates with glutamatergic innervation. Proc. Nutl. Acad. Sci. USA 75:2025-2029.
8. Cavalheiro, E.A., de Feo, M.R., and Ricci, G.F. (1983). Intracortical and intrahippocampal injections of kainic acid in developing rats: an electrographic study. Electroencephalogr. Clin. Neurophysiol. 56:480-486.
9. Drejer, J., Benveniste, H., Diemer, N.H., and Schousboe, A. (1985). Cellular origin of ischemia-induced glutamate release from brain tissue an vivo and in vitro. J. Neurochem. 45: 145-151.
10. Faden, A.I., Demediuk, P., Ranter, S.S., and Vink, R. (1989). The role of excitatory amino acids and NMDA receptors in traumatic brain injury. Science 244:798-800.
11. Faden, A.I., and Salzman, S. (1992). Pharmacological strategies in CNS trauma. Trends Pharmacol. Sci. 13:29-35.
12. Farber, N.B., Price, M.T., Labruyere, J., Fuller, T.A., and Olney, J.W. (1992). Age dependency of NMDA antagonist neurotoxicity. Soc. Neurosci. Abst. 18:1148
13. Feeney, D.M., Boyeson, M.G., Linn, R.T., Murray, H.M., and Dail, W.G. (1981). Responses to cortical injury: I. Methodology and local effects of contusions in the rat. Brain Res. 211:67-77.
14. Fix, A.S., Horn, J.W., Wightman, K.A., Johnson, C.A., Long, G.C., Storts, R.W. et al. (1993). Neuronal vacuolization and necrosis induced by the noncompetitive N-methyl-D-aspartate (NMDA) antagonist MK-801 (dizocilipine maleate): A light and electron microscopic evaluation of the rat retrosplenial cortex. Exp. Neural. 123:204-215.
15. Grafe, M.R. (1994). Developmental changes in the sensitivity of the neonatal rat brain to hypoxic/ischemic injury. Brain Res. 653:161-166.
16. Gennarelli, T.A. (1984). Emergency department management of head injuries. Emerg. Med. Clin. North Am. 2:749-760.
17. Gundersen, H.J.G., Bagger, P., Bendtsen, T.F., Evans, S.M., Korbo, L., Marcussen, N., Moller, A., Nielsen, K., Nyengaard, J.R., Pakkenberg, B., Sorensen, F.B., Vesterby, A. and West, M. J. (1988). The new stereological tools: Disector, fractionator, nucleator and point sampled intercepts and their use in pathological research and diagnosis. APMIS 96:857-881.
18. Hagberg, H., Diemer, N. H., and Andiné, P. (1992). Hypoxic-ischemic brain damage in the newborn rat: effect of NMDA- and AMPA-receptor antagonists. Biol. Neonat. 62:299.
19. Hu, B.-R., and Wieloch, T. (1995). Stress-induced inhibition of protein synthesis initiation: modulation of initiation factor 2 and guanine nucleotide exchange factor activities following transcient cerebral ischemia in the rat. J. Neurochem. 64:277-284.
20. Ikonomidou, C., Labruyere, J., Benz, A., and Olney, J. W. (1989). Antagonistic pharmacology of glutamate neurotoxicity in infant rat brain. Sac. Neurosci. Abstr. 15:767.
21. Ikonomidou, C., Mosinger, J.L., Shahid Salles, K., Labruyere, J., and Olney, J.W. (1989). Sensitivity of the developing rat brain to hypobaric/ischemic damage parallels sensitivity to N-methyl-aspartate neurotoxicity. J. Neurosci. 9:2809-2818.
22. Ikonomidou, C., and Olney, J. W. (1994). Developmental excitotoxicity for explaining neuropsychiatric disturbances. Neuropsychopharmacology 10:4485.
23. Ikonomidou, C., Price, M.T., Mosinger, J.L., Friedrich, G., Labruyere, J., Shahid Salles, K., Olney, J.W. (1989). Hypobaric-ischemic conditions produce glutamate-like cytopathology in infant rat brain. J. Neurosci. 9:1693-1700.
24. Ikonomidou, C., and Turski, L. (1995). Excitotoxicity and neurodegenerative diseases. Curr. Opinion Neurol. 8:487-497.
25. Katayama, Y., Becker, D.P., Tamura, T., and Hovda, D.A. (1990). Massive increase in extracellular potassium and the indiscriminate release of glutamate following concussive brain injury. J. Neurosurg. 73:889-900.
26. Kaufman, B.A., and Dacey, R.G. (1994). Acute care management of closed head injury in childhood. Ped. Ann. 23:18-28.
27. Lehmann, J., Schneider, J., McPherson, S., Murphy, D.E., Bernard, P., Tsai, C. et al. (1987). CPP, a selective N-methyl-D-aspartate (NMDA)-type receptor antagonist: characterization in vitro and in vivo. J. Pharmacol. Exp. Ther. 240:737-746.
28. Li, H., and Buchan, A.M. (1993). Treatment with an AMPA antagonist 12 hours following severe normothermic forebrain ischemia prevents CA1 neuronal injury. J. Cereb. Blood Flow Metab. 13:933-939.
29. McDonald, J.W., Silverstein, F.S., and Johnston, M.V. (1987). MK-801 protects the neonatal brain from hypoxic/ischemic damage. Eur. J. Pharmacol. 140:359-361.
30. McDonald, J.W., Silverstein, F.S., and Johnston, M.V. (1988). Neurotoxicity of N-methyl-D-aspartate is markedly enhanced in developing rat nervous system. Brain Res. 459:200-203.
31. McDonald, J.W., and Johnston, M.V. (1990). Physiological and pathological roles of excitatory amino acids during central nervous system development. Brain. Res. Rev. 15:41-70
32. McGlade-McCulloh, E., Yamamoto, H., Tan, S.-E., Brickey, D.A., and Soderling, T. S. (1993). Phosphorylation and regulation of glutamate receptors by calcium/calmodulin-dependent protein kinase II. Nature 362: 640-642.
33. McIntosh, T.K., Vink, R., Soares, H., Hayes, R., and Simon, R. (1990). Effect of noncompetitive blockade of N-methyl-D-aspartate receptors on the neurochemical sequelae of experimental brain injury. J. Neurochem. 55:1170-1179.
34. Monaghan, D.T., and Beaton, J.A. (1991). Diversity and organization of excitatory amino acid receptors in the CNS. In (V.I. Teichberg, and L. Turski, eds.) Excitatory Amino Acids and Second Messenger Systems, Springer, Berlin, pp. 1-16.
35. Monyer, H., Burnashev, N., Laurie, D.J., Sakmann, B., and Seeburg, P.H. (1994). Developmental and regional expression in the rat brain and functional properties of four NMDA receptors. Neuron 12:529-540.
36. Monyer, H., Nellgard, B., Seeburg, P.H., and Wieloch, T. (1991). Differential regulation of AMPA receptor splice variants in the CA1 region following ischemia. Soc. Neurosci. Abstr. 17:184.
37. Mosinger, J.L., Price, M.T., Bai, H.Y., Xiao, H., Wozniak, D.F., and Olney, J.W. (1991). Blockade of both NMDA and non-NMDA receptors is required for optimal protection against ischemic neuronal degeneration in the in vivo adult mammalian retina. Exp. Neurol. 113:10-17.
38. Nilsson, P., Hillered, L., Pontén, U., and Ungerstedt, U. (1990). Changes in cortical extracellular levels of energy-related metabolites and amino acids following concussive brain injury in rats. J. Cereb. Blood Flow Metab. 10:631-637.
39. Olney, J.W. (1971). Glutamate-induced neuronal necrosis in the infant mouse hypothalamus: An electron microscopic study. J. Neuropathol. Exp. Neural. 30:75-90.
40. Olney, J.W., Collins, R.C., Sloviter, R.S. (1986). Excitotoxic mechanisms of epileptic brain damage. Adv. Neurol. 44:857-877.
41. Olney, J.W., and Ikonomidou, C. (1991). Excitotoxic mechanisms operating in youth and old age. In (A. Kozikowski, ed.) Neurobiology of the NMDA Receptor, VCH, New York, pp. 187-202.
42. Olney, J.W., Ikonomidou, C., Mosinger, J.L., and Friedrich, G. (1989). MK-801 prevents hypobaric-ischemic neuronal degeneration in infant rat brain. J. Neurosci. 9:1701-1704.
43. Olney, J.W., Labruyere, J., Price, M.T. (1989). Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs. Science 244:1360-1362.
44. Olney, J.W., Labruyere, J., Wang, G., Sesma, M.A., Wozniak, D.F., Price, M.T. (1991). NMDA antagonist neurotoxicity: mechanism and protection. Science 254:1515-1518.
45. Olney, J.W., Sharpe, L.G., and Feigin, R.D. (1972). Glutamate-induced brain damage in infant primates. J. Neuropathol. Exp. Neural. 31:464-488.
46. Panter, S.S., and Faden, A.I. (1992). Pretreatment with NMDA antagonists limits release of excitatory amino acids following traumatic brain injury. Neurosci. Lett. 136:165-168.
47. Paxinos, G., and Watson, C. (1986). The Rat Brain in Stereotaxic Coordinates (Academic Press, San Diego, CA).
48. Pearl, T.M., Bedard, L., Kosatsky, T., Hockin, J.C., Todd, E.C.D., and Remis, R.S. (1990). An outbreak of toxic encephalopathy caused by eating mussels contaminated with domoic acid. N. Engl. J. Med. 322:1775-1780.
49. Pellegrini-Giampietro, D.E., Zukin, R.S., Bennett, M.V.L., Cho, S., and Pulsinelli, W.A. (1992). Switch in glutamate receptor subunit gene expression in CA1 subfield of hippocampus following global ischemia in rats. Proc. Natl. Acad. Sci. USA 89:10499-10503.
50. Povlishock, J.T. (1993). Traumatic brain injury. The pathobiology of injury and repair. In (A. Gorio) Neuroregeneration, Raven, New York, pp. 185-216.
51. Sheardown, M.J., Nielsen, E.O., Hansen, A.J., Jacobsen, P., and Honore, T. (1990). 2,3-Dihydroxy-6-nitro-7-sulfamoyl-benzo(f)quinoxaline: a neuroprotectant for cerebral ischemia. Science 247:571-574.
52. Takemoto, T. (1978). Isolation and structural identification of naturally occurring excitatory amino acids. In (E. McGeer, J.W. Olney, and P. McGeer, eds.) Kainic Acid as a Tool in Neurobiology. Raven, New York, 1-17.
53. Teitelbaum, J.S., Zatorre, R.J., Carpenter, S., Gendron, D., Evans, A.C., Gjedde, A., Cashman, N.R. (1990). Neurologic sequelae of domoic acid intoxication due to the ingestion of contaminated mussels. N. Engl. J. Med. 322:1781-1787.
54. Toulmond, S., Serrano, A., Benavides, J., and Scatton, B. (1993). Prevention by eliprodil (SL 82.0715) of traumatic brain damage in the rat. Existence of a large (18h) therapeutic window. Brain Res. 620:32-41.
55. Turski, L., Klockgether, T., Turski, W.A., Ikonomidou, C., Schwarz, M., and Sontag, K.-H. (1988). Muscle relaxant action of excitatory amino acid antagonists: Sites of action. In (E.A. Cavalheiro, J. Lehmann, and L. Turski, eds) Frontiers in Excitatory Amino Acid Research. Liss, New York, pp. 343-350.
56. Wrathall, J.R., Teng, Y.D., Choiniere, D., Mundt, D.J. (1992). Evidence that local non-NMDA receptors contribute to functional deficits in contusive spinal cord injury. Brain Res. 586:140-143.